FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/092092 [Registered on: 31/07/2025] Trial Registered Prospectively
Last Modified On: 30/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study on the role of preventive antibiotics in reducing infections after kidney stone removal surgery 
Scientific Title of Study   Evaluation of prophylactic antibiotic usage in prevention of postoperative infection in patients undergoing percutaneous nephrolithotomy 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vasavi kesana 
Designation  post graduate 
Affiliation  sri manakula vinayagar medical college and hospital 
Address  Room no 59 surgery opd department of surgery sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, puducherry

Pondicherry
PONDICHERRY
605107
India 
Phone  7207563661  
Fax    
Email  vasavikesana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ANTO 
Designation  PROFESSOR 
Affiliation  Sri Manakula vinayagar medical college and hospital 
Address  Room no 59 surgery opd department of surgery sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, puducherry

Pondicherry
PONDICHERRY
605107
India 
Phone  9941470970  
Fax    
Email  drantomed@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR ANTO 
Designation  PROFESSOR 
Affiliation  Sri Manakula vinayagar medical college and hospital 
Address  Room no 59 surgery opd department of surgery sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, puducherry

Pondicherry
PONDICHERRY
605107
India 
Phone  9941470970  
Fax    
Email  drantomed@gmail.com  
 
Source of Monetary or Material Support  
Sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, 605107 puducherry, India  
 
Primary Sponsor  
Name  vVASAVI KESANA 
Address  Room no 59 surgery opd department of surgery sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, puducherry ,605107, India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vasavi kesana  Sri manakula vinayagar medical college and hospital  Sri manakula vinayagar medical college and hospital, kalitheerthalkuppam, Madagadipet, puducherry
Pondicherry
PONDICHERRY 
07207563661

vasavikesana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMVMCH   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N20||Calculus of kidney and ureter,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Single preoperative dosage of Injection Amikacin  To compare the effectiveness of single dose versus multidose prophylactic amikacin regimen in preventing postoperative infections among patients undergoing percutaneous nephrolithotomy 
Intervention  Three preoperative dosage of Injection amikacin  To compare the effectiveness of single dose versus multidose prophylactic amikacin regimen in preventing postoperative infections among patients undergoing percutaneous nephrolithotomy Total duration of 18 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Age more than 18 years
2) Patients of male and female sex
3) Upper urinary tract stones of any size for which PCNL was recommended
4) Preoperative urine culture negative patients  
 
ExclusionCriteria 
Details  ) Antibiotic use within 2 weeks before randomization
2) contraindiaction to Injection amikacin
3)patients who are unable to tolerate surgery and anesthesia
4) patients who are having spinal deformity
5) pregnant or lactating female patients 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
The study is aimed to analyze the effectiveness of prophylactic antibiotics usage in prevention of postoperative infection rate in patients undergoing percutaneous nephrolithotomy   18 months 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="126"
Sample Size from India="126" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Postoperative infections are a common complication following Percutaneous Nephrolithotomy (PCNL), even in patients with negative preoperative urine cultures. While prophylactic antibiotics are routinely used to prevent such infections, there is ongoing debate over the optimal regimen, particularly between single-dose and multi-dose protocols. This randomized controlled trial aims to compare the effectiveness of single-dose versus multi-dose prophylactic Amikacin in preventing postoperative infections in PCNL patients with sterile urine cultures. By focusing on this specific patient subgroup and incorporating robust randomization and blinding methods, the study seeks to generate evidence-based recommendations that enhance patient outcomes while supporting antibiotic stewardship. The results may contribute to standardizing prophylactic antibiotic protocols for PCNL procedures. 
Close